Personal profile
Headline
ASSOCIATE CLINICAL PROFESSOR | Ophthalmology ASSOCIATE CLINICAL PROFESSOR | Medical Education
Biography
Dr. Rhee evaluates and treats individuals with diseases of the cornea. She is a clinical and surgical instructor for the Mount Sinai residency program in ophthalmology, and has surgical expertise in refractive procedures such as LASIK and PRK, corneal, and cataract surgery. Dr. Rhee is the co-director of Refractive Surgery Services at Mount Sinai. Dr. Rhee has published research on the use of antibiotic therapy for ocular infections and corneal disease in top journals, including Cornea and the American Journal of Ophthalmology. Dr. Rhee serves as associate director of Ophthalmology for Mount Sinai at the Elmhurst Hospital Center. She is a member of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery, and is the associate medical director of the Eye Bank for Sight Restoration of New York. Dr. Rhee is board certified by the American Board of Ophthalmology. Dr. Rhee completed subspecialty training in diseases of the cornea and refractive surgery at the New York Eye and Ear Infirmary following a residency in ophthalmology at the Eye and Ear Institute of Pittsburgh. Dr. Rhee earned her M.D. from Mount Sinai School of Medicine where she was part of the Humanities and Medicine Program which offered early acceptance to a selected group of undergraduates. She graduated summa cum laude from Princeton University. Before pursuing a career in medicine, Dr. Rhee studied piano, cello, and music composition at the Juilliard School in New York City. Certification Ophthalmology Clinical Focus Cataract Surgery http://www.mountsinai.org/patient-care/health-library/treatments-and-procedures/corneal-transplant Corneal Transplant http://www.mountsinai.org/patient-care/health-library/treatments-and-procedures/lasik LASIK Laser Vision Correction Education MD, Mount Sinai School of Medicine Internship, Internal Medicine Cabrini Medical Center Residency, Ophthalmology Eye & Ear Institute University of Pittsburgh Fellowship, Cornea, External Diseases New York Eye and Ear Infirmary Languages English, Korean, Spanish
External positions
Medical Director, Eye Bank for Sight Restoration, New York, New York
Fingerprint
Dive into the research topics where Michelle Rhee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Management of Dry Eye Disease with Artificial Tears Containing Hyaluronic Acid and Trehalose: A Narrative Review
Barnett, M., Rhee, M. K. & Donaldson, K. E., 2026, In: Clinical Ophthalmology. 20, p. 1-14 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Corrigendum: Early Real-World Patient and Staff Experience With an Intracanalicular Dexamethasone Insert (Clin Ophthalmol. (2024), 18, (1391-1401), 10.2147/OPTH.S448973)
Nijm, L., Matossian, C. & Rhee, M. K., 2025, In: Clinical Ophthalmology. 19, p. 385-386 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
A 25-Year-Old App Designer Who Wears Contacts and Eyelash Extensions
Jacobs, E. J. & Rhee, M. K., 1 Jan 2024, Dry Eye Disease: A Practical Guide. CRC Press, p. 59-66 8 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Bacterial Keratitis Preferred Practice Pattern®
American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel, Apr 2024, In: Ophthalmology. 131, 4, p. P87-P133Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
Blepharitis Preferred Practice Pattern®
American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel, Apr 2024, In: Ophthalmology. 131, 4, p. P50-P86Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations
Press/Media
-
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD; Third positive pivotal Phase III clinical trial of AstraZeneca's IL-33-targeting biologic further demonstrates its benefits in COPD
20/04/26 → 21/04/26
18 items of Media coverage
Press/Media
-
AstraZeneca: Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
20/04/26
1 item of Media coverage
Press/Media
-
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD; First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two repli
27/03/26 → 28/03/26
15 items of Media coverage
Press/Media
-
AstraZeneca: Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
27/03/26
1 item of Media coverage
Press/Media
-